Products

DESCRIPTION

• Overview
• Product Description
• Product Details
• Application&Function
• Specification

Overview

Basic Info.

Model NO.	XMHT-Acyclovir
Certification	GMP, HSE, ISO 9001, USP, BP
Suitable for	Elderly, Adult
State	Powder
Purity	>99%
Product Name	Acyclovir
Name	Acyclovir Powder
Appearance	White Powder
Color	White
CAS No.	59277-89-3
Mf	C8h11n5o3
MW	225.20464
Melting Point	256-257℃
Boiling Point	595 °C at 760 Mmhg
Application	Pharmaceutical
Grade	Pharmaceutical Grade
Specific	COA
Shelf Life	2 Years
Assay	HPLC 99%
Test Method	HPLC
Transport Package	Negotiable
Specification	99%
Trademark	XMHT
Origin	Shaanxi Xi'an
Production Capacity	3000kg/Month

Product Description

Antiviral Raw Acyclovir Powder AcyclovirProduct Description

Product Details

Product name	Acyclovir
Appearance	White Powder
CAS No.	59277-89-3
MF	C8H11N5O3
MW	225.20464

Acyclovir is a synthetic antiviral agent belonging to the nucleoside analog class, characterized by its selective activity against certain herpesviruses. It exerts its antiviral effect by being converted to its active form within infected cells, where it inhibits viral DNA polymerase, a key enzyme involved in viral genome replication, thereby blocking viral proliferation and spread. With a well-defined mechanism of action and favorable pharmacokinetic properties, it is clinically used for the treatment and prevention of infections caused by susceptible viruses, including mucosal, cutaneous, and systemic infections. When administered as prescribed, acyclovir exhibits a good safety profile with manageable adverse reactions, primarily affecting the gastrointestinal and nervous systems in rare cases, making it a widely used and reliable therapeutic option for viral infections targeted by its mechanism.Application&Function

Acyclovir is a synthetic nucleoside antiviral compound that exerts targeted antiviral effects by selectively inhibiting the DNA polymerase activity of herpes viruses, interfering with the synthesis and replication of viral DNA, thereby preventing the proliferation and spread of viruses in the body. It has potent inhibitory activity against various herpes viruses such as herpes simplex virus and varicella-zoster virus, which can effectively shorten the course of viral infection, alleviate symptoms such as blisters and pain, and reduce the risk of infection recurrence. It is commonly used in the treatment and prevention of diseases such as mucocutaneous herpes infection, chickenpox, and herpes zoster. This drug has a precise mechanism of action and low toxicity to host cells, with wide clinical applications. Its use should follow professional guidance, and the dosage form and dosage should be reasonably selected according to the type of infection and the characteristics of the condition to ensure the antiviral effect and reduce potential risks. Acyclovir's selectivity for viral DNA polymerase enables it to specifically target infected cells without significantly affecting normal cellular processes, contributing to its favorable safety profile. When administered in a timely manner after the onset of infection, it can effectively inhibit viral replication at an early stage, thereby reducing the severity of symptoms and preventing the development of complications. In the treatment of recurrent herpes infections, it can be used as a prophylactic agent to reduce the frequency of recurrence and improve the quality of life of patients. Specification